Crosstalk between protein kinase C α and transforming growth factor β signaling mediated by Runx2 in intestinal epithelial cells

[1]  A. Aiba,et al.  Runx2 regulates chromatin accessibility to direct the osteoblast program at neonatal stages , 2022, Cell reports.

[2]  J. Black,et al.  PKCα and PKCδ: Friends and Rivals , 2022, The Journal of biological chemistry.

[3]  J. Black,et al.  A novel antiproliferative PKCα-Ras-ERK signaling axis in intestinal epithelial cells , 2022, The Journal of biological chemistry.

[4]  J. Black,et al.  The complexities of PKCα signaling in cancer. , 2020, Advances in biological regulation.

[5]  Qifa Li,et al.  miR‐181b‐induced SMAD7 downregulation controls granulosa cell apoptosis through TGF‐β signaling by interacting with the TGFBR1 promoter , 2018, Journal of cellular physiology.

[6]  C. Morrison,et al.  Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium , 2018, Cell reports.

[7]  B. Arumugam,et al.  Characterization of Runx2 phosphorylation sites required for TGF‐β1‐mediated stimulation of matrix metalloproteinase‐13 expression in osteoblastic cells , 2018, Journal of cellular physiology.

[8]  C. Deng,et al.  The role of TGF-β/SMAD4 signaling in cancer , 2018, International journal of biological sciences.

[9]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[10]  Ruiying Dang,et al.  MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1 , 2017, Human Cell.

[11]  Yan Zhou,et al.  MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1 , 2017, Human Cell.

[12]  B. Jung,et al.  Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer. , 2017, Gastroenterology.

[13]  A. Hata,et al.  TGF-β Signaling from Receptors to Smads. , 2016, Cold Spring Harbor perspectives in biology.

[14]  J. Potter,et al.  Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC). , 2016, Carcinogenesis.

[15]  J. Black,et al.  Protein Kinase Cα (PKCα) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation* , 2016, The Journal of Biological Chemistry.

[16]  E. Petricoin,et al.  Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression. , 2016, Cancer cell.

[17]  P. Tsao,et al.  Transcription Factor Runx2 Promotes Aortic Fibrosis and Stiffness in Type 2 Diabetes Mellitus. , 2015, Circulation research.

[18]  R. G. Richards,et al.  Role and regulation of RUNX2 in osteogenesis. , 2014, European cells & materials.

[19]  S. Knapp,et al.  A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics , 2014, Nature chemical biology.

[20]  Christopher M. Williams,et al.  Protein Kinase C (cid:2) (PKC (cid:2) ) Regulates Bone Architecture and Osteoblast Activity * , 2014 .

[21]  J. Black,et al.  Differential Regulation of Cyclin D1 Expression by Protein Kinase C α and ϵ Signaling in Intestinal Epithelial Cells* , 2014, The Journal of Biological Chemistry.

[22]  N. Barker.  Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration , 2013, Nature Reviews Molecular Cell Biology.

[23]  B. Pasche,et al.  TGFBR1 and cancer susceptibility. , 2014, Transactions of the American Clinical and Climatological Association.

[24]  G. Stein,et al.  Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis , 2014, Genome Biology.

[25]  A. Fasano,et al.  Major signaling pathways in intestinal stem cells. , 2013, Biochimica et biophysica acta.

[26]  J. Black,et al.  Protein kinase C signaling and cell cycle regulation , 2013, Front. Immun..

[27]  J. Massagué.  TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.

[28]  C. Ge,et al.  Interactions between extracellular signal‐regulated kinase 1/2 and P38 Map kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  E. Kinoshita,et al.  Phos‐tag SDS‐PAGE systems for phosphorylation profiling of proteins with a wide range of molecular masses under neutral pH conditions , 2012, Proteomics.

[30]  Steven J. Seedhouse,et al.  Protein Kinase Cα Signaling Regulates Inhibitor of DNA Binding 1 in the Intestinal Epithelium* , 2011, The Journal of Biological Chemistry.

[31]  N. Yi,et al.  Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs , 2010, Journal of experimental & clinical cancer research : CR.

[32]  David R. Liu,et al.  A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.

[33]  C. Ge,et al.  Identification and Functional Characterization of ERK/MAPK Phosphorylation Sites in the Runx2 Transcription Factor* , 2009, The Journal of Biological Chemistry.

[34]  G. Xiao,et al.  Post-translational Regulation of Runx2 in Bone and Cartilage , 2009, Journal of dental research.

[35]  L. Augenlicht,et al.  PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. , 2009, Experimental cell research.

[36]  K. Moriyama,et al.  Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1/2 and Protein Kinase C Signaling* , 2009, Journal of Biological Chemistry.

[37]  G. Stein,et al.  Co-stimulation of the Bone-related Runx2 P1 Promoter in Mesenchymal Cells by SP1 and ETS Transcription Factors at Polymorphic Purine-rich DNA Sequences (Y-repeats)* , 2009, Journal of Biological Chemistry.

[38]  Chiang-Ching Huang,et al.  Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. , 2009, Cancer research.

[39]  S. Liyanarachchi,et al.  Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer , 2008, Science.

[40]  Je-Yong Choi,et al.  Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. , 2008, Gene.

[41]  J. Hauser,et al.  Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. , 2008, Cancer research.

[42]  B. Pasche,et al.  Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development. , 2007, Human molecular genetics.

[43]  H. Friess,et al.  Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer , 2007, British Journal of Cancer.

[44]  J. Black,et al.  Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells* , 2007, Journal of Biological Chemistry.

[45]  Boris Pasche,et al.  TGF-β signaling alterations and susceptibility to colorectal cancer , 2007 .

[46]  J. Seoane.  Escaping from the TGFβ anti-proliferative control , 2006 .

[47]  R. Wells,et al.  Repetitive exposure to TGF-β suppresses TGF-β type I receptor expression by differentiated osteoblasts , 2006 .

[48]  M. Leitges,et al.  Protein kinase c alpha but not PKC zeta suppresses intestinal tumor formation in Apc(Min/+) mice , 2006 .

[49]  J. Black,et al.  Protein Kinase C α Signaling Inhibits Cyclin D1 Translation in Intestinal Epithelial Cells* , 2006, Journal of Biological Chemistry.

[50]  M. Leitges,et al.  Protein Kinase C A but not PKCZ Suppresses Intestinal Tumor Formation in Apc Mice , 2006 .

[51]  F. Macrae,et al.  A review of Juvenile Polyposis Syndrome , 2005, Journal of gastroenterology and hepatology.

[52]  R. Beauchamp,et al.  A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. , 2005, Neoplasia.

[53]  Hans Clevers,et al.  Signaling pathways in intestinal development and cancer. , 2004, Annual review of cell and developmental biology.

[54]  Françoise Gellibert,et al.  Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. , 2004, Journal of medicinal chemistry.

[55]  Jennifer A. Clark,et al.  Involvement of the ERK Signaling Cascade in Protein Kinase C-mediated Cell Cycle Arrest in Intestinal Epithelial Cells* , 2004, Journal of Biological Chemistry.

[56]  F. Luft,et al.  Glucose-Induced TGF-&bgr;1 and TGF-&bgr; Receptor-1 Expression in Vascular Smooth Muscle Cells Is Mediated by Protein Kinase C-&agr; , 2003 .

[57]  J. Alexander,et al.  Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7 , 2003, Molecular and Cellular Endocrinology.

[58]  P. Ducy,et al.  Characterization of an Osteoblast-specific Enhancer Element in the CBFA1 Gene* , 2002, The Journal of Biological Chemistry.

[59]  A. Lund,et al.  RUNX: a trilogy of cancer genes. , 2002, Cancer cell.

[60]  Jennifer A. Clark,et al.  Protein Kinase C Signaling Mediates a Program of Cell Cycle Withdrawal in the Intestinal Epithelium , 2000, The Journal of cell biology.

[61]  Stephen N. Jones,et al.  Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene , 2000, Journal of cellular physiology.

[62]  A. Barber.  Friends and Rivals , 1999 .

[63]  T. Mayhew,et al.  Epithelial integrity, cell death and cell loss in mammalian small intestine. , 1999, Histology and histopathology.

[64]  N. Petrelli,et al.  Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. , 1998, Gastroenterology.

[65]  A. G. de Herreros,et al.  Protein Kinase C-α Activity Inversely Modulates Invasion and Growth of Intestinal Cells* , 1998, The Journal of Biological Chemistry.

[66]  G. Stein,et al.  CBFa(AML/PEBP2)‐related elements in the TGF‐β type I receptor promoter and expression with osteoblast differentiation , 1998, Journal of cellular biochemistry.

[67]  Hisao Ito,et al.  Down‐regulation of protein kinase C‐α detected in human colorectal cancer , 1998 .

[68]  J. Black,et al.  Protein Kinase C Isozyme-mediated Cell Cycle Arrest Involves Induction of p21waf1/cip1 and p27kip1 and Hypophosphorylation of the Retinoblastoma Protein in Intestinal Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[69]  Luzhe Sun,et al.  Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells* , 1996, The Journal of Biological Chemistry.

[70]  J. Barnard,et al.  CANCER BIOLOGY: Type II TGFβ receptor expression in intestinal cell lines and in the intestinal tract , 1996 .

[71]  G. Karsenty,et al.  Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene , 1995, Molecular and cellular biology.

[72]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[73]  J. Black,et al.  Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ , 1994, The Journal of cell biology.

[74]  B. Marian,et al.  Five of six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon. , 1994, Carcinogenesis.

[75]  L. Gold,et al.  Localization of transforming growth factor β isoforms in the normal murine small intestine and colon , 1993 .

[76]  M. Sporn,et al.  TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. , 1993, British Journal of Cancer.

[77]  K. M. Mulder,et al.  Role of receptor complexes in resistance or sensitivity to growth inhibition by TGFβ in intestinal epithelial cell clones , 1993, Journal of cellular physiology.

[78]  J. Zhao,et al.  Relationship of levels and kinetics of H-ras expression to transformed phenotype and loss of TGF-beta 1-mediated growth regulation in intestinal epithelial cells. , 1993, Experimental cell research.

[79]  H. Moses,et al.  TGF‐β regulation of epithelial cell proliferation , 1992, Molecular reproduction and development.

[80]  J. Willson,et al.  TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector , 1992, The Journal of cell biology.

[81]  W. Telford,et al.  Evaluation of glucocorticoid‐induced DNA fragmentation in mouse thymocytes by flow cytometry , 1991, Cell proliferation.

[82]  R. Coffey,et al.  Regulation of intestinal epithelial cell growth by transforming growth factor type beta. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[83]  J. Massagué,et al.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. , 1989, The Journal of biological chemistry.